Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06343220 · ClinicalTrials.gov registry record
Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research
A clinical trial, sponsored by Huntington Study Group.
- Completed
- Registry status
- 131
- Enrollment target
NCT06343220: Completed study, sponsored by Huntington Study Group.
NCT06343220 is a clinical trial that has completed, run by Huntington Study Group. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06343220 has completed, sponsored by Huntington Study Group.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
Study Summary
The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.
Primary Outcome
To examine prospective research participants' awareness, willingness, and ability to participate in clinical research for HD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2025-12-22 |
What the finished NCT06343220 record still lists
NCT06343220 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06343220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06343220 about?
NCT06343220 is a clinical study titled "Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research". The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.
What is the current status of trial NCT06343220?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2024-04-10. Estimated completion is 2025-12-22.
Who is sponsoring clinical trial NCT06343220?
This trial is sponsored by Huntington Study Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI